Todd Harris, Head of Corporate Development at Sienna Biopharmaceuticals, Inc. (SNNA), sold 35,202 shares at $20.00 ($705K) on 2018-03-07, disclosed to the SEC on 2018-03-09.
Open-market sale of $705k SNNA by Head of Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 3,704 | $74K | 10.5% |
| 2 | $20.03 | 14,530 | $291K | 41.3% |
| 3 | $20.03 | 14,530 | $291K | 41.3% |
| 4 | $20.01 | 2,438 | $49K | 6.9% |
| Total | $20.03 avg | 35,202 | $705K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |